Biogen Inc. insider Priya Singhal sold 431 shares of the stock on Tuesday, September 3rd at an average price of $204.22.
Priya Singhal has recently sold 431 shares of Biogen Inc. (NASDAQ:BIIB) stock. Read More »
The law firm of Kessler Topaz Meltzer & Check, LLP has alerted investors about a securities class action lawsuit that has been filed.
In New York on June 27, 2024, Bragar Eagel & Squire, P.C., a well-known law firm specializing in shareholder rights, is reminding investors about ongoing class action lawsuits on their behalf.
Visit thefly.com to stay updated on the latest financial news in real-time. The website is renowned for its market intelligence and offers a streaming news feed to keep readers informed.
Read More: https://www.bizjournals.com/boston/news/2024/06/06/petri-dish-biogen-strand-takeda.html?ana=RSS&s=article_search
Robbins LLP is alerting investors that a class action lawsuit has been filed by a shareholder on behalf of those who bought or acquired Biogen Inc. securities between February 3…
Robbins LLP informs investors that a shareholder has filed a class action lawsuit on behalf of individuals and entities who bought or obtained Biogen Inc. (NASDAQ: BIIB) securities between February 3…
In New York on June 1, 2024, Bragar Eagel & Squire, P.C., a well-known firm specializing in stockholder rights, is reminding investors about a class action lawsuit that has been filed against…
This article will focus on the largest publicly traded biotech company that tops our list of the 20 Biggest Publicly Traded Biotech Companies.
The largest biotechnology company that is publicly traded. Read More »
DEADLINE ALERT: Faruqi & Faruqi, LLP is investigating claims on behalf of investors of Biogen. The investigation was announced by PR Newswire.
Stay updated with the latests analysis and insights fromm etfsector.com